# ENDRA Life Sciences Inc.: Form 8-K, filed Jul 29, 2019

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2019-07-29
- Accepted by EDGAR: Jul 29, 2019, 08:40 ET
- Period: 2019-07-26
- Accession: 0001654954-19-008564
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000165495419008564/ndra_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000165495419008564/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000165495419008564/ndra_8k.htm

Filed Jul 29, 2019.
Source: SEC EDGAR, the filing index for accession 0001654954-19-008564. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.